

ImmunityBio shares rise after the FDA accepted ANKTIVA's sBLA for NMIBC, with Phase 2/3 data showing durable bladder cancer outcomes.
You can purchase shares of Virtus Biotech ETF (ARCA:BBP) through any online brokerage.
There are no as such competitors for Virtus Biotech ETF.
There is no analysis for Virtus Biotech ETF to provide a consensus price target.
The stock price for Virtus Biotech ETF (ARCA: BBP) is $ last updated .
There are no upcoming dividends for Virtus Biotech ETF.
Virtus Biotech ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Virtus Biotech ETF.
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one...